10 Pharmaceuticals Stocks to Sell Now

10 Pharmaceuticals Stocks to Sell Now

This week, the overall grades of 10 Pharmaceuticals stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).

Taro Pharmaceutical Industries Ltd. (TARO) experiences a ratings drop this week, going from last week’s D to a F. Taro Pharmaceutical Industries Ltd. is engaged in developing, manufacturing, and marketing prescription and over-the-counter pharmaceutical products, as well as active pharmaceutical ingredients in the United States, Canada and Israel. The company also gets F’s in earnings revisions. For more information, get Portfolio Grader’s complete analysis of TARO stock.

This week, Perrigo Co. Plc (PRGO) drops from a D to a F rating. Perrigo Co. Plc manufactures, distributes and markets pharmaceutical and nutritional products. The company also gets F’s in operating margin growth, earnings growth, and free cash flow. For more information, get Portfolio Grader’s complete analysis of PRGO stock.

Dermira Inc (DERM) declines this week from a C to a D. The company also gets F’s in sales growth, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of DERM stock.

Horizon Pharma plc (HZNP) slips from a C to a D this week. Horizon Pharma plc is a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company also gets F’s in operating margin growth, earnings growth, and earnings momentum. For more information, get Portfolio Grader’s complete analysis of HZNP stock.

This is a rough week for Sucampo Pharmaceuticals, Inc. Class A (SCMP). The company’s rating falls to D from the previous week’s C. Sucampo Pharmaceuticals, Inc. Class A is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body. For more information, get Portfolio Grader’s complete analysis of SCMP stock.

Innoviva, Inc.’s (INVA) rating weakens this week, dropping to a D versus last week’s C. The company also gets F’s in earnings revisions and earnings surprise. For more information, get Portfolio Grader’s complete analysis of INVA stock.

TherapeuticsMD, Inc. (TXMD) gets weaker ratings this week as last week’s D drops to a F. TherapeuticsMD, Inc. operates as a women’s healthcare product company in the United States. The company also gets F’s in earnings surprise and return on equity. For more information, get Portfolio Grader’s complete analysis of TXMD stock.

Titan Pharmaceuticals, Inc. (TTNP) is having a tough week. The company’s rating falls from a C to a D. The company also gets F’s in earnings revisions and free cash flow. For more information, get Portfolio Grader’s complete analysis of TTNP stock.

Aradigm Corporation (ARDM) earns a F this week, moving down from last week’s grade of D. The company also gets F’s in sales growth, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of ARDM stock.

This week, Acasti Pharma Inc. Class A’s (ACST) rating worsens to a F from the company’s D rating a week ago. Acasti Pharma Inc. Class A is a pharmaceutical company that develops drugs for cardiovascular diseases. The company also gets F’s in sales growth, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of ACST stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2016/12/10-pharmaceuticals-stocks-to-sell-now-3/.

©2019 InvestorPlace Media, LLC